Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
14.86
-0.34 (-2.24%)
At close: Mar 6, 2026, 4:00 PM EST
15.17
+0.31 (2.09%)
After-hours: Mar 6, 2026, 7:55 PM EST
Dyne Therapeutics Employees
Dyne Therapeutics had 258 employees as of December 31, 2025. The number of employees increased by 67 or 35.08% compared to the previous year.
Employees
258
Change (1Y)
67
Growth (1Y)
35.08%
Revenue / Employee
n/a
Profits / Employee
-$1,729,512
Market Cap
2.45B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Apellis Pharmaceuticals | 739 |
| Adaptive Biotechnologies | 624 |
| Beam Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Ocular Therapeutix | 325 |
| Wave Life Sciences | 317 |
| Day One Biopharmaceuticals | 178 |
DYN News
- 4 days ago - Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 9 days ago - Dyne Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 12 days ago - Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference - GlobeNewsWire
- 4 weeks ago - Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Dyne Therapeutics: 2026 Catalysts Point To Further Upside - Seeking Alpha
- 6 weeks ago - Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 - GlobeNewsWire
- 7 weeks ago - Dyne Therapeutics, Inc. (DYN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire